SCWorx Corp. (WORX) Stock Analysis
DELISTED 2026
What happened to SCWorx Corp. (WORX) stock?
SCWorx Corp. (WORX) no longer trades on public markets. It was delisted in August 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SCWorx Corp. (WORX) trades at $5.50. SCWorx Corp. provides healthcare information technology solutions, focusing on data normalization and interoperability. Market cap: $88.0M, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for WORX: WORX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WORX against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
WORX: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
SCWorx Corp. (WORX) Healthcare & Pipeline Overview
SCWorx Corp. delivers healthcare IT solutions, specializing in data normalization and interoperability for hospitals and healthcare facilities. The company's offerings include data analytics, EMR management, and a ticketing platform for mixed martial arts, positioning it as a diversified player in the healthcare information services sector.
What Is the Investment Thesis for WORX?
SCWorx Corp. operates in the healthcare information technology sector, a market with significant growth potential. The company's focus on data normalization and interoperability addresses a critical need for healthcare providers. However, with a market capitalization of $88.0M and negative profitability (P/E of -0.31 and Profit Margin of -139.7%), the company faces significant challenges. The high beta of 2.02 indicates high volatility. Growth catalysts include potential expansion of its data analytics services and increased adoption of its CageTix platform. The company's ability to achieve profitability and manage its operating expenses will be crucial for its long-term success. Investors should closely monitor the company's financial performance and its ability to execute its growth strategy.
Based on FMP financials and quantitative analysis
WORX Key Highlights
Market Cap of $88.0M indicates a micro-cap company with limited resources and higher risk.
- P/E ratio of -0.31 reflects negative earnings and suggests the company is not currently profitable.
- Profit Margin of -139.7% indicates significant losses and operational inefficiencies.
- Gross Margin of 26.1% suggests some ability to generate revenue above the cost of goods sold, but needs improvement.
- Beta of 2.02 indicates the stock is more volatile than the market, suggesting higher risk.
Who Are WORX's Competitors?
WORX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CCM Concord Medical Services Holdings Limited | $5.09 | +6.04% | — | |
| COCH Envoy Medical, Inc. | $0.75 | +1.41% | $15.6M | — |
| NIVF NewGenIvf Group Limited | $0.56 | -1.26% | 43 | |
| CCLD CareCloud, Inc. | $2.63 | -0.38% | $112M | 69 |
| AUGX Augmedix, Inc. | $2.35 | -0.21% | $116M | 58 |
| ONVVF Oneview Healthcare PLC | $0.16 | +0.00% | $123M | 60 |
| OPRX OptimizeRx Corporation | $8.08 | +0.87% | $152M | 87 |
| VRHI Veri Medtech Holdings Inc. | $2.35 | +0.00% | $46.9M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WORX's Key Strengths?
Specialized healthcare data normalization and interoperability solutions.
- Established relationships with hospitals and health systems.
- Proprietary CageTix ticketing platform for MMA events.
- Experience in navigating the healthcare IT landscape.
What Are WORX's Weaknesses?
Low market capitalization and limited financial resources.
- Negative profitability and high operating expenses.
- High stock volatility.
- Reliance on a small number of employees.
What Could Drive WORX Stock Higher?
Potential new contracts for data normalization and interoperability services.
- Expansion of the CageTix platform into new markets.
- Increased demand for healthcare data analytics solutions.
What Are the Key Risks for WORX?
Negative return on equity (-34.7%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the healthcare IT market.
- Regulatory changes and compliance requirements.
- Negative profitability and high operating expenses.
- High stock volatility.
What Are the Growth Opportunities for WORX?
- Expansion of Data Analytics Services: SCWorx can leverage its data analytics capabilities to offer more comprehensive solutions to healthcare providers. The healthcare analytics market is projected to reach $75 billion by 2026, driven by the need for better patient outcomes and cost reduction. By focusing on predictive analytics and personalized medicine, SCWorx can capture a larger share of this market. Timeline: 2-3 years.
- Increased Adoption of CageTix Platform: The CageTix platform offers a unique opportunity to diversify revenue streams. The mixed martial arts (MMA) event ticketing market is growing, with regional events gaining popularity. By expanding the platform's reach and offering value-added services, SCWorx can increase its revenue from this segment. Timeline: 1-2 years.
- Strategic Partnerships and Acquisitions: SCWorx can pursue strategic partnerships with other healthcare IT providers to expand its product offerings and market reach. Acquisitions of complementary businesses can also accelerate growth. The healthcare IT market is consolidating, and strategic alliances can provide a competitive advantage. Timeline: Ongoing.
- Focus on Interoperability Solutions: With the increasing emphasis on interoperability in healthcare, SCWorx can focus on developing solutions that enable seamless data exchange between different healthcare systems. The interoperability market is expected to grow significantly, driven by regulatory mandates and the need for better care coordination. Timeline: 2-3 years.
- Sales of PPE and COVID-19 Test Kits: SCWorx's recent involvement in selling PPE and COVID-19 test kits presents a short-term revenue opportunity. While this is not a core business, it can provide additional revenue and cash flow during the pandemic. However, the company needs to manage this business carefully to avoid supply chain disruptions and quality issues. Timeline: Ongoing.
What Threats Does WORX Face?
- Intense competition in the healthcare IT market.
- Regulatory changes and compliance requirements.
- Potential supply chain disruptions and quality issues related to PPE and COVID-19 test kits.
- Economic downturn affecting healthcare spending.
What Are WORX's Competitive Advantages?
- Specialized healthcare data normalization and interoperability solutions.
- Established relationships with hospitals and health systems.
- Proprietary CageTix ticketing platform for MMA events.
- Experience in navigating the healthcare IT landscape.
What Does WORX Do?
SCWorx Corp., based in Tampa, Florida, develops and markets healthcare information technology solutions designed to improve healthcare processes and information flow within hospitals and other healthcare facilities across the United States. The company's core offerings revolve around data content and services related to the repair, normalization, and interoperability of information for healthcare providers. SCWorx also provides big data analytics tailored for the healthcare industry, enabling providers to gain insights from their data. The company's solutions include virtualized item master file repair, expansion and automation, EMR (Electronic Medical Record) management, CDM (Charge Description Master) management, contract management, request for proposal automation, rebate management, integration of acquired management, big data analytics modeling, data integration and warehousing, and ScanWorx. SCWorx also operates CageTix, an online event ticketing platform focused on serving regional mixed martial arts events. In recent times, the company has also been involved in selling personal protective equipment (PPE) and COVID-19 rapid test kits. SCWorx sells its solutions and services through a direct sales force and through distribution and reseller partnerships, targeting hospitals and health systems.
What Products and Services Does WORX Offer?
- Develops healthcare information technology solutions.
- Markets solutions to improve healthcare processes and information flow.
- Provides data content and services for data repair and normalization.
- Offers big data analytics for the healthcare industry.
- Operates a virtualized item master file repair and automation service.
- Provides EMR and CDM management solutions.
- Operates an online event ticketing platform for mixed martial arts events.
- Sells personal protective equipment (PPE) and COVID-19 rapid test kits.
How Does WORX Make Money?
- Sells healthcare IT solutions and services to hospitals and health systems.
- Generates revenue from data normalization and interoperability services.
- Earns revenue from the CageTix ticketing platform.
- Generates revenue from sales of PPE and COVID-19 test kits.
What Industry Does WORX Operate In?
SCWorx Corp. operates within the healthcare information technology (IT) sector, which is experiencing substantial growth driven by the increasing adoption of digital health solutions, electronic health records (EHRs), and the need for improved data interoperability. The market is competitive, with established players like Cerner (now Oracle), Epic Systems, and smaller, specialized firms such as Computer Programs and Systems (CCM), Computer Task Group (CDT), and COCH focusing on niche areas. SCWorx's focus on data normalization and big data analytics positions it to capitalize on the growing demand for data-driven healthcare solutions.
Who Are WORX's Key Customers?
- Hospitals
- Health systems
- Healthcare providers
- Mixed martial arts event organizers and attendees
Company Profile
SCWorx Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Middleton, US. The company is led by CEO Timothy Andrew Hannibal. WORX has traded publicly since 2016.
How SCWorx Corp. Is Valued
SCWorx Corp. carries a market capitalization of $88.0M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for SCWorx Corp. stands at -34.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -30.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.19 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
SCWorx Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 61.68 places it in the safe zone, indicating low near-term bankruptcy risk.
WORX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in SCWorx's growth prospects, indicating that those closest to the company believe in its future.
- Community sentiment has been increasingly positive, with discussions highlighting the company's innovative solutions in data management.
- The recent expansion of partnerships in the healthcare sector has bolstered market perception, positioning SCWorx as a key player in a growing industry.
- Investors are optimistic about SCWorx's potential to capitalize on the increasing demand for efficient data solutions.
Bear Case
- Concerns about the company's financial stability have surfaced, with some investors questioning its ability to maintain profitability in the near term.
- Recent social media discussions show a divide, with a notable portion of the community expressing skepticism regarding SCWorx's long-term strategy.
- The competitive landscape in the data management sector is intensifying, raising fears that SCWorx may struggle to differentiate itself.
- Market sentiment has been tempered by broader economic uncertainties, leading some investors to adopt a more cautious approach towards SCWorx.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WORX Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Jul 13, 2021
Leadership: Timothy Andrew Hannibal
CEO
Information on Timothy Andrew Hannibal's background is not available in the provided data. Further research would be needed to determine his career history, education, previous roles, and credentials.
Track Record: Information on Timothy Andrew Hannibal's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership.
WORX OTC Market Information
WORX trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
Common Questions About WORX (Healthcare)
What happened to SCWorx Corp. (WORX) stock?
SCWorx Corp. (WORX) no longer trades on public markets. It was delisted in August 2026. The figures below are historical and are not a current quote.
Can I still buy WORX shares?
No. WORX stopped trading on public markets in August 2026, so the shares are not available through a broker. Anything you see quoted for WORX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before WORX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to SCWorx Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does SCWorx Corp. do?
SCWorx Corp. is a healthcare information technology company that develops and markets solutions to improve healthcare processes and information flow. The company's core offerings include data normalization, interoperability services, and big data analytics for healthcare providers.
What are the main risks for WORX?
SCWorx faces several risks, including intense competition in the healthcare IT market, regulatory changes and compliance requirements, and potential supply chain disruptions related to PPE and COVID-19 test kits. The company's negative profitability and high operating expenses also pose a significant risk. Additionally, the high stock volatility (beta of 2.02) could lead to substantial price swings. Investors should be aware of these risks before investing in SCWorx.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Information on CEO background and track record is unavailable.
- AI analysis is pending.